Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Tax Provisions: 2024-2025

Historic Tax Provisions for Silence Therapeutics (SLN) over the last 2 years, with Sep 2025 value amounting to $1,000.

  • Silence Therapeutics' Tax Provisions fell 97.96% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $21,000, marking a year-over-year decrease of 97.20%. This contributed to the annual value of $845,000 for FY2024, which is 11.61% down from last year.
  • As of Q3 2025, Silence Therapeutics' Tax Provisions stood at $1,000, which was down 90.00% from $10,000 recorded in Q2 2025.
  • Over the past 5 years, Silence Therapeutics' Tax Provisions peaked at $324,000 during Q4 2024, and registered a low of $1,000 during Q3 2025.